Cookson Peirce & Co’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-7,888
Closed -$1.16M 180
2020
Q3
$1.16M Buy
7,888
+4,342
+122% +$621K 0.09% 88
2020
Q2
$438K Buy
3,546
+501
+16% +$58.9K 0.04% 108
2020
Q1
$294K Buy
+3,045
New +$294K 0.03% 115

Other funds holding RGEN

Cookson Peirce & Co's RGEN Position: Q4 2020 in Review

Cookson Peirce & Co sold out of Repligen (RGEN) in Q4 2020, closing a stake of 7,888 shares — an estimated $1.16M sold.

Cookson Peirce & Co first reported a position in RGEN in Q1 2020 and held it in 3 quarters. The position peaked at $1.16M in Q3 2020. 449 funds tracked by Wall St. Rank hold RGEN as of Q4 2020.

  • Cookson Peirce & Co reported no remaining Repligen position as of Q4 2020 after selling out during the quarter.
  • Cookson Peirce & Co sold 7,888 Repligen shares in Q4 2020, an estimated $1.16M.
  • Cookson Peirce & Co first reported a position in Repligen in Q1 2020 and held it in 3 quarters.
  • Cookson Peirce & Co's Repligen position peaked at $1.16M in Q3 2020.
  • 449 funds tracked by Wall St. Rank held Repligen as of Q4 2020.

Based on Cookson Peirce & Co's 13F filing for Q4 2020, filed 10 Feb 2021.